Custom Search
FDA Information
Etidronate was first approved by the FDA in 1977.
Nevertheless, FDA-approval of etidronate for the treatment of osteoporosis has been denied twice, first in 1991 and again in November 1994 - osteoporosis remains an off-label use for this medication.
On the other hand, generic oral etidronate tablets were first approved by the FDA in January 2003. However, as of March 2005, Didronel IV® has been discontinued from manufacture by MGI Pharma in the U.S.
Please visit the official site of the FDA for further information.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?